Cancer and Metastasis Reviews

, Volume 8, Issue 4, pp 285–297 | Cite as

Studies of human breast cancer metastasis using nude mice

  • Janet E. Price
  • Ruo Dan Zhang


Athymic nude mice have been used in recent years to study the biology of human tumors and to assess therapeutic responses in vivo rather than just in vitro. Some human tumors metastasize in nude mice, providing model systems for analyzing various aspects of the metastatic phenotype of human neoplasms. For breast carcinomas, however, the tumor-take rate of surgical specimens is low, and only a limited number of cell lines proliferate in nude mice. The site of injection of the breast carcinoma cells is important; tumors grow at a lower inoculum dose and with shorter latent intervals after implantation in the mammary fatpad of nude mice than after injection in the subcutis. One breast carcinoma cell line, MDA-MB-435, metastasizes from mammary fatpad tumors to lymph nodes, lungs, and other visceral organs. In contrast, two other cell lines show lower metastatic ability. Intravenous injection and injection of tumor cells into the internal carotid artery of nude mice produces lung and brain metastases, respectively, thus simulating the arrest and organ colonizing steps of the metastatic cascade. These different techniques demonstrate the potential of experimental studies of human breast cancer growth and metastasis using nude mice.

Key words

breast carcinoma metastasis nude mice orthotopic injection 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Poste G, Fidler IJ: The pathogenesis of cancer metastasis. Nature 283: 139–146, 1979Google Scholar
  2. 2.
    Alley MC, Scudiero DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH, Boyd MR: Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 48: 589–601, 1988Google Scholar
  3. 3.
    McFadden R, Kwok CS: Mathematical model of simultaneous diffusion and binding of antitumor antibodies in multicellular human tumor spheroids. Cancer Res 48: 4032–4037, 1988Google Scholar
  4. 4.
    Hanauske AR, von Hoff DD: Clinical correlations with the human tumor cloning assay. Cancer Invest 3: 541–551, 1985Google Scholar
  5. 5.
    Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM, McEvan N: A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47: 3239–3245, 1987Google Scholar
  6. 6.
    Hendrix MJC, Gehlsen KR, Wagner HN, Rodney SR, Misiorowski RL, Meyskens FLJr.: In vitro quantitation of melanoma tumor cell invasion. Clin Expl Metastasis 3: 221–233, 1985Google Scholar
  7. 7.
    Li L, Price JE, Fan D, Zhang RD, Bucana CD, Fidler IJ: Correlation of the growth capacity of human tumor cells with their in vivo proliferative capacity at specific metastatic sites. JNCI 81: 1406–1412, 1989Google Scholar
  8. 8.
    Wingen F, Spring H, Schmahl D: Antimetastatic effects of razoxane in a rat osteosarcoma model. Clin Exp Metastasis 5: 9–16, 1987Google Scholar
  9. 9.
    Saiki I, Lida J, Murata J, Ogawa R, Nishi N, Sugimura K, Tokura S, Azuma I: Inhibition of the metastasis of murine malignant melanoma by synthetic polymeric peptides containing core sequences of cell-adhesive molecules. Cancer Res 49: 3815–3822, 1989Google Scholar
  10. 10.
    Rygaard J, Povlsen CO: Heterotransplantation of a human malignant tumor to nude mice. Acta Pathol Microbiol Scand Sect Pathol A 77: 758–760, 1969Google Scholar
  11. 11.
    Giovanella BC, Fogh J: The nude mouse in cancer research. Adv Cancer Res 44: 69–120, 1985Google Scholar
  12. 12.
    Fogh J, Giovanella BC: The Nude Mouse in Experimental and Clinical Research, Vols 1 and 2. Academic Press, Inc., New York, 1982Google Scholar
  13. 13.
    Sordat B (ed): Immune-Deficient Animals. 4th International Workshop on Immune-Deficient Animals in Experimental Research, Chexbres 1982. Karger, Basel, 1984Google Scholar
  14. 14.
    Rygaard J. Brunnern, Graem N, Spang-Thomsen M (eds): Immune-Deficient Animals in Biomedical Research. 5th International Workshop on Immune-Deficient Animals, Copenhagen 1985. Karger, Basel, 1987Google Scholar
  15. 15.
    Sebestany A, Taylor-Papadimitriou J, Ceriani R, Millis R, Schmitt C, Trevan D: Primary human breast carcinomas transplanted in the nude mouse. JNCI 63: 1331–1337, 1979Google Scholar
  16. 16.
    Rae-Venter B, Reid LM: Growth of human breast carcinomas in nude mice and subsequent establishment in tissue culture. Cancer Res 40: 95–100, 1980Google Scholar
  17. 17.
    Giovanella BC, Vardeman DM, Williams LJ, Taylor DJ, Stehlin JS, Ullrich A, Gary HE, Slamon DJ: Poor prognosis of breast cancer patients whose tumor took in nude mice. Correlation with amplification and overexpression of the HER-2/neu oncogene. Abstract. Proceedings of the American Association for Cancer Research 30: 60, 1989Google Scholar
  18. 18.
    Kyriazis A, DiPersio L, Michael JG, Pesce AJ: Influence of the mouse hepatitis virus (MHV) infection on the growth of human tumors in the athymic mouse. Int J Cancer 23: 402–409, 1979Google Scholar
  19. 19.
    Nomura T: Genetic and microbiological control of immunodeficient laboratory animals. In: Sordat B (ed) Immune-Deficient Animals. 4th International Workshop on Immune-Deficient Animals in Experimental Research, Chexbres 1982. Karger, Basel, 1984, pp 160–171Google Scholar
  20. 20.
    Neulat-Duga I, Sheppel A, Marty C, Lacroux F, Pourrat J, Caveriviere P, Delsol G: Metastases of human tumor xenografts in nude mice. Invasion Metastasis 4: 209–224, 1984Google Scholar
  21. 21.
    Manning JK, Reed ND, Jutila JW: Antibody response to Escherichia coli lipopolysaccharide and type III pneumococcal polysacchoride by congenitally thymusless (nude) mice. J Immunol 108: 1470–1472, 1972Google Scholar
  22. 22.
    Johnson WJ, Balish E: Macrophage function in germ-free, athymic (nu/nu), and conventional-flora (nu/+) mice. J Reticuloendoth Soc 28: 55–66, 1980Google Scholar
  23. 23.
    Hanna N, Davis TW, Fidler IJ: Environmental and genetic factors determine the level of NK activity of nude mice and affect their suitability as models of experimental metastasis. Int J Cancer 30: 371–376, 1982Google Scholar
  24. 24.
    Meltzer MS: Tumoricidal responses in vitro of peritoneal macrophages from conventionally housed and germ-free nude mice. Cell Immunol 22: 176–181, 1976Google Scholar
  25. 25.
    Fidler IJ, Pollack VA, Hanna N: The use of nude mice for studies of cancer metastasis. In: Sordat B (ed) Immune-Deficient Animals, 4th International Workshop on Immune-Deficient Animals in Experimental Research. Chexbres 1982. Karger, Basel, 1984, pp 328–338Google Scholar
  26. 26.
    Medawar PB: Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain and to subcutaneous tissue and to the anterior chamber of the eye. Br J Exp Pathol 29: 58–69, 1948Google Scholar
  27. 27.
    Auerbach R, Morrissey LW, Sidky YA: Regional differences in the incidence and growth of mouse tumors following intradermal and subcutaneous inoculation. Cancer Res 38: 1739–1744, 1978Google Scholar
  28. 28.
    Kyriazis AA, Kyriazis AP: Preferential sites of growth of human tumors in nude mice following subcutaneous transplantation. Cancer Res 40: 4509–4511, 1980Google Scholar
  29. 29.
    Cornil I, Man S, Fernandez B, Kerbel RS: Enhanced tumorigenicity, melanogenesis and metastases of a human malignant melanoma after subdermal implantation in nude mice. JNCI 81: 938–944, 1989Google Scholar
  30. 30.
    Ahlering TE, Dubeau L, Jones PA: A new in vivo model to study invasion and metastasis of a human bladder carcinoma. Cancer Res 47: 6660–6665, 1987Google Scholar
  31. 31.
    Blair PB, Moretti RL: The mammary fatpad as a privileged transplantation site. Transplantation 5: 542–544, 1967Google Scholar
  32. 32.
    Miller FR, Medina D, Heppner GH: Preferential growth of mammary tumors in intact mammary fatpads. Cancer Res 41: 3863–3867, 1981Google Scholar
  33. 33.
    Wicha MS, Liotta LA, Garbisa S, Kidwell WR: Basement membrane collagen requirements for attachment and growth of mammary epithelium. Exp Cell Res 124: 181–190, 1979Google Scholar
  34. 34.
    Durban EM: Extracellular matrix effects on mammary cell behavior. In: Medina D, Kidwell W, Heppner GH, Anderson E (eds) Cellular and Molecular Biology of Mammary Cancer, Plenum Press, New York, 1987, pp 81–104Google Scholar
  35. 35.
    Faulkin LJJr, DeOme KB: Regulation of growth and spacing of gland elements in the mammary fatpad of the C3H mouse. JNCI 24: 953–969, 1960Google Scholar
  36. 36.
    Sheffield LG, Welsch CW: Transplantation of human breast epithelia to mammary gland-free fatpads of athymic nude mice: Influence of mammatrophic hormones on growth of breast epithelia. Int J Cancer 41: 713–719, 1988Google Scholar
  37. 37.
    Welsch CW, O'Connor DH, Aylsworth CF, Sheffield LG: Normal but not carcinomatous primary rat mammary epithelium: Readily transplanted to and maintained in the athymic nude mouse. JNCI 78: 557–565, 1987Google Scholar
  38. 38.
    Miller ER, McInerny D: Epithelial component of hosttumor interactions in the orthotopic site preference of a mouse mammary tumor. Cancer Res 48: 3698–3701, 1988Google Scholar
  39. 39.
    Outzen HC, Custer RP: Growth of human normal and neoplastic mammary tissues in the cleared mammary fatpad of the nude mouse. JNCI 55: 1461–1463, 1975Google Scholar
  40. 40.
    Cailleau R, Olvie M, Cruciger QVJ: Long-term human breast carcinoma cell lines of metastatic origin: Preliminary characterization. In Vitro 14: 911–915, 1978Google Scholar
  41. 41.
    Price JE, Polyzos A, Zhang RD, Daniels LM: Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res (in press), 1989Google Scholar
  42. 42.
    Heppner GH: Tumor heterogeneity. Cancer Res 44: 2259–2265, 1984Google Scholar
  43. 43.
    Folkman J, Klagsbrun M: Angiogenic factors. Science 235: 442–447, 1987Google Scholar
  44. 44.
    Smith KA, Hill SA, Begg AC, Denekamp J: Validation of the fluorescent dye Hoechst 33342 as a vascular space marker in tumours. Br J Cancer 57: 247–253, 1988Google Scholar
  45. 45.
    Brunner N, Osborne CK, Spang-Thomsen M: Endocrine therapy of human breast cancer grown in nude mice. Breast Cancer Res Treat 10: 229–242, 1987Google Scholar
  46. 46.
    Shafic SM, Grantham FH: Role of hormones in the growth and regression of human breast cancer cells (MCF-7) transplanted into athymic nude mice. JNCI 67: 51–56, 1981Google Scholar
  47. 47.
    Osborne CK, Hobbs K, Clark GM: Effects of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice. Cancer Res 45: 584–590, 1985Google Scholar
  48. 48.
    Leung CKH, Shiu RPC: Required presence of both estrogen and pituitary factors for the growth of human breast cancer cells in athymic nude mice. Cancer Res 41: 546–551, 1981Google Scholar
  49. 49.
    Weinstein L: Impairment of the hypothalamo-pituitaryovarian axis of the athymic ‘nude’ mouse. Mech Ageing Develop 8: 63–68, 1978Google Scholar
  50. 50.
    Lippman ME, Dickson RB, Gelmann EP, Knabbe C, Kasid A, Bates S, Swain S: Mechanisms of estrogenic and antiestrogenic regulation of growth of human breast carcinoma. In: Klijn JGM (ed) Hormonal Manipulation of Cancer: Peptides, Growth Factors, and New (Anti) Steroidal Agents. Raven Press, New York, 1987, pp 381–405Google Scholar
  51. 51.
    Meyvisch C, Mareel M: Site-induced differences in spontaneous metastasis of MO4 mouse fibrosarcoma cells. Invasion Metastasis 5: 185–192, 1985Google Scholar
  52. 52.
    Fidler IJ: Rationale and methods for the use of nude mice to study the biology and therapy of human cancer metastasis. Cancer Metastasis Rev 5: 29–49, 1986Google Scholar
  53. 53.
    Sordat B, Wang WR: Human colorectal tumour xenografts in nude mice: Expression of malignancy. Bchring Inst Mitt 74: 291–300, 1984Google Scholar
  54. 54.
    Bresalier RS, Raper SE, Hujanen ES, Kim YS: A new animal model for human colon cancer metastasis. Int J Cancer 39: 625–630, 1987Google Scholar
  55. 55.
    Morikawa K, Walker SM, Nakajima M, Pathak S, Jessup JM, Fidler IJ: Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice. Cancer Res 48: 6863–6871, 1988Google Scholar
  56. 56.
    Naito S, von Eschenbach AC, Fidler IJ: Different growth pattern and biologic behavior of human renal cell carcinoma implanted into different organs of nude mice. JNCI 78: 377–385, 1987Google Scholar
  57. 57.
    Sekikawa K, Arends JW, Verstijnen CPHJ, van der Linden E, Dinjens W, Schutte B, Bosman FT: Influence of implantation site on growth, antigen expression and metastatic potential of human colonic cancer HT-29 and 5583 xenografts in nude mice. Invasion Metastasis 8: 238–252, 1988Google Scholar
  58. 58.
    Cajot JF, Sordat B, Bachmann F: Human primary colon carcinomas xenografted into nude mice. II. Modulation of tissue plasminogen activator activity by the host tissue environment. JNCI 77: 1099–1107, 1986Google Scholar
  59. 59.
    Pourreau-Schneider N, Delori P, Boutiere B, Arnoux D, George F, Sampol J, Martin PM: Modulation of plasminogen activator systems by matrix components in two breast cancer cell lines: MCF-7 and MDA-MB-231. JNCI 81: 259–266, 1989Google Scholar
  60. 60.
    Shafie SM, Liotta LA: Formation of metastasis by human breast carcinoma cells (MCF-7) in nude mice. Cancer Lett 11: 81–87, 1980Google Scholar
  61. 61.
    Bergman BL, Scott RW, Bajpai A, Watts S, Baker JB: Inhibition of tumor-cell-mediated extracellular matrix destruction by a fibroblast proteinase inhibitor, protease nexin I. Proc Natl Acad Sci USA 83: 996–1000, 1986Google Scholar
  62. 62.
    Soule HD, Vazquez J, Long A, Albert S, Brennan M: A human cell line from a pleural effusion derived from a breast carcinoma. JNCI 51: 1409–1413, 1973Google Scholar
  63. 63.
    Ozello L, Sordat B: Behavior of tumors produced by transplantation of human mammary cell lines in athymic nude mice. Eur J Cancer 16: 553–559, 1980Google Scholar
  64. 64.
    Ozzello L, Leuchtenberger C: Metastatic potential of SK-Br-3 cells treated with L-cysteine or ascorbic acid. In: Hellmann K, Hilgard P, Eccles S (eds) Metastases: Clinical and Experimental Aspects. Martinus Nijhoff, The Hague, 1980, pp 232–236Google Scholar
  65. 65.
    Osborne CK, Hobbs K, Trent JM: Biological differences among MCF-7 human breast cancer cell lines from different laboratories. Breast Cancer Res Treat 9: 111–121, 1987Google Scholar
  66. 66.
    Weiss L: Principles of Metastasis. Academic Press, Orlando, FL, 1985Google Scholar
  67. 67.
    Sordat BCM, Ueyama Y, Fogh J: Metastasis of tumor xenografts in the nude mouse. In: Fogh J, Giovanella BC (eds) The Nude Mouse in Experimental and Clinical Research, Vol 2. Academic Press, New York, 1984, pp 95–147Google Scholar
  68. 68.
    Lockshin A, Giovanella BC, Kozielski T, Stehlin JSJr: Determination of cytotoxicity in vivo using IIIIndium-labeled human tumor cells. Cancer Lett 24: 179–185, 1984Google Scholar
  69. 69.
    Price JE, Daniels LM, Campbell DE, Giavazzi R: Organ distribution of experimental metastases of a human colorectal carcinoma injected in nude mice. Clin Exp Metastasis 7: 55–68, 1989Google Scholar
  70. 70.
    McNeill PL, Muthukrishnan L, Warder E, D'Amore PA: Growth factors are released by mechanically wounded endothelial cells. J Cell Biol 109: 811–822, 1989Google Scholar
  71. 71.
    DiStefano A, Yap Y, Hortobagyi GN, Blumenschein GR: The natural history of breast cancer patients with brain metastasis. Cancer 44: 1913–1918, 1979Google Scholar
  72. 72.
    Schackert G, Price JE, Bucana CD, Fidler IJ: Unique patterns of brain metastasis produced by different human carcinomas in athymic nude mice. Int J Cancer 44: 892–897, 1989Google Scholar
  73. 73.
    Levy JA, White AC, McGrath CM: Growth and histology of a human mammary-carcinoma cell line at different sites in the athymic mouse. Br J Cancer 45: 375–383, 1982Google Scholar
  74. 74.
    Jessup JM, Giavazzi R, Morikawa M, Campbell DE, Hostetter R, Cleary KR, Atkinson EN, Fidler IJ: Growth of human colorectal carcinoma (HCC) cells isolated from surgical specimens predict disease recurrence in patients operated upon for cure. Abstract. Proceedings of the American Association for Cancer Research 30: 231, 1989Google Scholar
  75. 75.
    Slamon DJ, Clark GM, Wong SC, Levin WS, Ullrich A, McGuire WL: Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177–182, 1987Google Scholar
  76. 76.
    Wright C, Angus B, Nicholson S, Sainsbury JRC, Cairns J, Gullick WJ, Kelly P, Harris AL, Horne CHW: Expression of c-erbB-2 oncoprotein: A prognostic indicator in human breast cancer. Cancer Res 49: 2087–2090, 1989Google Scholar
  77. 77.
    Berger MS, Locher GW, Saurer S, Gullick WJ, Waterfield MD, Groner B, Hynes NE: Correlation of c-erb-B-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. Cancer Res 48: 1238–1241, 1988Google Scholar
  78. 78.
    Ali IU, Lidereau R, Callahan R: Heterogeneity of genetic alterations in primary human breast tumors. In: Lippman ME, Dickson RB (eds) Breast Cancer: Cellular and Molecular Biology. Academic Publishers, Boston, 1988, pp 25–48Google Scholar
  79. 79.
    Dickson RB, Lippman ME: Control of human breast cancer by estrogen, growth factors and oncogenes. In: Lippman ME, Dickson RB (eds) Breast Cancer: Cellular and Molecular Biology. Academic Publishers, Boston, 1988, pp 119–165Google Scholar
  80. 80.
    Kraus MH, Popescu NC, Amsbaugh SC, King CR: Overexpression of the EGF-receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms. EMBO 6: 605–610, 1987Google Scholar
  81. 81.
    McGuire WL: Prognostic factors for recurrence and survival in human breast cancer. Breast Cancer Res Treat 10: 5–9, 1987Google Scholar
  82. 82.
    Shankar V, Ciardiello F, Kim N, Derynck R, Liscia DS, Merlo G, Langton BC, Sheer D, Callahan R, Bassin RH, Lippman ME, Hynes N, Salomon DS: Transformation of an established mouse mammary epithelial cell line following transfection with a human transforming growth factor alpha cDNA. Mol Carcinog 2: 1–11, 1989Google Scholar
  83. 83.
    Drebin JA, Link VC, Weinberg RA, Greene MI: Inhibition of tumor growth by a monoclonal antibody reactive with an oncogene-encoded tumor antigen. Proc Natl Acad Sci USA 83: 9129–9133, 1986Google Scholar
  84. 84.
    Sainsbury JRC, Farndon JR, Sherbert GV, Harris AL. Epidermal growth factor receptors and oestrogen receptors in human breast cancer. Lancet 1: 364–366, 1985Google Scholar
  85. 85.
    Masui H, Kawamoto T, Sato JD, Wolf B, Sato G, Mendelsohn J: Growth inhibition of human tumor cells in athymic mice by anti-epidermal growth factor receptor monoclonal antibodies. Cancer Res 44: 1002–1007, 1984Google Scholar
  86. 86.
    Aboud-Pirak E, Hurwitz E, Pirak ME, Bellot F, Schlessinger J, Sela M: Efficacy of antibodies to epidermal growth factor receptor against KB carcinoma in vitro and in nude mice. JNCI 80: 1605–1611, 1988Google Scholar

Copyright information

© Kluwer Academic Publishers 1989/1990

Authors and Affiliations

  • Janet E. Price
    • 1
  • Ruo Dan Zhang
    • 1
  1. 1.Department of Cell BiologyThe University of Texas M.D. Anderson Cancer CenterHoustonUSA

Personalised recommendations